Tumor suppressor genes and their underlying interactions in paclitaxel resistance in cancer therapy
2016 · Cancer Cell International · 75 citations
https://doi.org/10.1186/s12935-016-0290-9
S
Shilian Hu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
79
Papers
1.4K
Citations
22
h-index
29
i10-index
Shilian Hu is an academic researcher from University of Science and Technology of China. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Epigenetics and DNA Methylation & Mycobacterium research and diagnosis. The author has an h-index of 22, co-authored 68 publications.
Papers by this author
worksPrognostic Role of Human Epidermal Growth Factor Receptor in Gastric Cancer: A Systematic Review and Meta-analysis
2013 · Archives of Medical Research · 61 citations
https://doi.org/10.1016/j.arcmed.2013.07.001
MiR–20a-5p promotes radio-resistance by targeting Rab27B in nasopharyngeal cancer cells
2017 · Cancer Cell International · 45 citations
https://doi.org/10.1186/s12935-017-0389-7
Paraoxonase 3 is involved in the multi-drug resistance of esophageal cancer
2018 · Cancer Cell International · 17 citations
https://doi.org/10.1186/s12935-018-0657-1
MOESM1 of MiR–20a-5p promotes radio-resistance by targeting Rab27B in nasopharyngeal cancer cells
2017 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.c.3706789_d1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat